EUVIMEDEUVIMED entdecken
Multizentrische StudieVergleichsstudieBeobachtungsstudie

Drug‐Coated Balloons Versus Drug‐Eluting Stents for De Novo Ostial Left Circumflex Lesions: The International Multicenter DCB‐CIRCO Registry

Francesco Tartaglia iD, Sandeep Basavarajaiah iD, Mauro Gitto iD, Ottavia F Cozzi, Leoni Knobel, Leah Stutz, Quan Tran, Harindi Loku Waduge, Pier Pasquale Leone iD, Gianmaria Calamita, Chandan Deepak Bhavnani, Matteo Maurina iD und 13 weitere

Catheterization and Cardiovascular Interventions · 2025-11 · 106 (5) · 2958-2968

DOI: 10.1002/ccd.70154 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, online erschienen am 05.09.2025. Verfasst von Francesco Tartaglia und 24 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Humanitas University, Milan, Italy. Hauptthemen laut MEDLINE: Drug-Eluting Stents, Coronary Artery Disease, Coated Materials, Biocompatible, Cardiac Catheters. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Percutaneous coronary intervention (PCI) with drug‐eluting stents (DES) on ostial left circumflex (oLCx) is associated with a high rate of adverse events.

Aims

This study aims to compare drug‐coated balloons (DCB) and DES in the treatment of oLCx lesions.

Methods

Consecutive patients undergoing DCB‐PCI of de novo oLCx lesions (isolated or in the context of a distal left main bifurcation) in eight international centers from 2018 to 2023 were retrospectively enrolled and compared with a historical cohort of patients who received PCI with DES. The primary endpoint was the 2‐year incidence of target lesion failure (TLF), a composite of target lesion revascularization (TLR), target vessel‐myocardial infarction and cardiac death, at time‐to‐first event analysis. Propensity‐score matching was adopted to adjust for clinical and angiographic confounders.

Results

A total of 152 patients were included in the DCB group and 351 patients in the DES group. Patients in the DES group had more multivessel disease (94.6% vs. 82.7%, p < 0.001) but shorter lesions (18.0 [interquartile range, IQR: 15.0−28.0] vs. 25.5 [17.4−40.0] mm, p < 0.001) than those in the DCB group. Fluoroscopy time (20.0 [IQR: 14.0−28.2] vs. 31.0 [21.0−45.5] min, p < 0.001) and amount of contrast used (150 [IQR: 120−220] vs. 200 [140−250] mL, p = 0.006) were significantly lower in DCB‐PCI than DES‐PCI. The 2‐year rate of TLF was similar in the two groups (19.0% in the DCB group vs. 19.8% in the DES group, hazard ratio [HR]: 1.05, 95% confidence interval [CI] 0.64−1.75). This result remained consistent in the 126 pairs of patients obtained after propensity score matching.

Conclusions

In a multinational observational retrospective real‐world study including patients undergoing PCI on oLCx, no difference in TLF rate was detected between PCI with DCB and PCI with DES at a midterm follow‐up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug-Eluting StentsCoronary Artery DiseaseCoated Materials, BiocompatibleCardiac CathetersAngioplasty, Balloon, CoronaryHumansRetrospective StudiesMaleRegistriesFemaleMiddle AgedAgedTime FactorsTreatment OutcomeProsthesis DesignRisk FactorsRisk Assessment

Stichwörter der Autor:innen

drug‐coated balloonsleft circumflexostiumpercutaneous coronary intervention

Substanzen

Coated Materials, Biocompatible

Autor:innen und Institutionen

  • Department of Biomedical Sciences, Humanitas University, Milan, Italy.
  • IRCCS Humanitas Research Hospital, Milan, Italy.
  • Heartlands Hospital, University Hospitals, Birmingham, UK.
  • Cardiology Division, Heart Center, Luzerner Kantonsspital, Lucerne, Switzerland.
  • Cardiology, Worcestershire Royal Hospital, Worcester, UK.
  • Division of Cardiology, Montefiore Medical Center, New York, New York, USA.

ORCID-Profile: Francesco Tartaglia, Sandeep Basavarajaiah, Mauro Gitto, Pier Pasquale Leone, Matteo Maurina, Gabriele Gasparini, Giulio G Stefanini, Antonio Mangieri, Antonio Colombo

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Tartaglia, F., Basavarajaiah, S., Gitto, M., Cozzi, O. F., Knobel, L., Stutz, L., Tran, Q., Loku Waduge, H., Leone, P. P., Calamita, G., Deepak Bhavnani, C., Maurina, M., Morosato, M., Ielasi, A., Gasparini, G., Routledge, H., Selvaraj, K., Testa, L., Reimers, B., …, & Colombo, A. (2025). Drug‐Coated Balloons Versus Drug‐Eluting Stents for De Novo Ostial Left Circumflex Lesions: The International Multicenter DCB‐CIRCO Registry. Catheterization and Cardiovascular Interventions, 106(5), 2958-2968. https://doi.org/10.1002/ccd.70154

Vancouver

Tartaglia F, Basavarajaiah S, Gitto M, Cozzi OF, Knobel L, Stutz L, et al. Drug‐Coated Balloons Versus Drug‐Eluting Stents for De Novo Ostial Left Circumflex Lesions: The International Multicenter DCB‐CIRCO Registry. Catheterization and Cardiovascular Interventions. 2025;106(5):2958-2968. doi:10.1002/ccd.70154

BibTeX
@article{Tartaglia2025,
  author = {Tartaglia, Francesco and Basavarajaiah, Sandeep and Gitto, Mauro and Cozzi, Ottavia F and Knobel, Leoni and Stutz, Leah and Tran, Quan and Loku Waduge, Harindi and Leone, Pier Pasquale and Calamita, Gianmaria and Deepak Bhavnani, Chandan and Maurina, Matteo and Morosato, Michele and Ielasi, Alfonso and Gasparini, Gabriele and Routledge, Helen and Selvaraj, Kamaraj and Testa, Luca and Reimers, Bernhard and Bossard, Matthias and Cuculi, Florim and Regazzoli, Damiano and Stefanini, Giulio G and Mangieri, Antonio and Colombo, Antonio},
  title = {Drug‐Coated Balloons Versus Drug‐Eluting Stents for De Novo Ostial Left Circumflex Lesions: The International Multicenter DCB‐CIRCO Registry},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  volume = {106},
  number = {5},
  pages = {2958--2968},
  doi = {10.1002/ccd.70154}
}
Kostenlos starten →